Nuclear Medicine

Prof. Dr. Filiz Özülker

Doctor and researcher İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi İstanbul
Thyroid Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNuclear Medicinesaglik.gov.trFrom source
  • Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Area of workThyroid NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications67 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0003-2075-1429ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563433/doktorlarimiz.html#filiz-ozulkersaglik.gov.tr

Scientific work

Publications on Thyroid Neoplasms

67 publications

  1. Correlación entre los parámetros metabólicos derivados de la PET/TC con [18F]FDG y la expresión de PD-L1 en pacientes con cáncer de pulmón no microcítico

    Revista Española de Medicina Nuclear e Imagen Molecular, 2026

    DOI 10.1016/j.remn.2025.500258 Source: OpenAlex

  2. Combining Clinical Variables with 18F-FDG-PET/CT Metrics Enhances Overall Survival Prediction in Gastric Cancer

    Gazi Medical Journal, 2026

    DOI 10.12996/gmj.2026.4594 Open-access full textSource: OpenAlex

  3. Baseline [¹⁸F]FDG PET/CT metrics and systemic inflammatory indices in relation to overall survival in a real-world breast cancer cohort

    Clinical and Translational Imaging, 2026

    DOI 10.1007/s40336-026-00767-7 Source: OpenAlex

  4. The effect of digital PET/CT and reconstruction algorithms on semi-quantitative values and Deauville scoring in patients with lymphoma.

    PubMed, 2025

    DOI 10.1967/s002449912904 PMID 41389257 Source: OpenAlex

  5. Is There Novel 18F-FDG Biodistribution in the Digital PET/CT Era? A Real-World Data Analysis

    Cancer Biotherapy and Radiopharmaceuticals, 2025

    DOI 10.1089/cbr.2024.0226 PMID 39866138 Source: ORCID

  6. Correlation between F-18 FDG PET/CT-derived metabolic parameters and PD-L1 expression in non-small cell lung cancer patients

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2025

    DOI 10.1016/j.remnie.2025.500258 PMID 41314286 Source: OpenAlex

  7. The effect of reconstruction algorithms on semi-quantitative measurements in 18F-FDG PET/CT imaging.

    PubMed, 2024

    DOI 10.1967/s002449912721 PMID 39097805 2 citations (OpenAlex) Source: OpenAlex

  8. Isolated Castrate-resistant Prostate Cancer Metastasis to Both Adrenal Glands Detected on 68Ga PSMA PET/CT

    Molecular imaging and radionuclide therapy, 2023

    DOI 10.4274/mirt.galenos.2023.03780 PMID 37870375 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  9. Prevalence and Clinical Significance of Incidental Focal 18F-FDG Uptake in Colon on PET/CT Imaging

    Molecular Imaging and Radionuclide Therapy, 2022

    DOI 10.4274/mirt.galenos.2022.38247 PMID 35770960 6 citations (Europe PMC) Open-access full textSource: ORCID

  10. Contribution of Lower Extremity 68Ga PSMA PET/CT Imaging to Diagnosis and Treatment in Prostate Cancer

    European Archives of Medical Research, 2022

    DOI 10.4274/eamr.galenos.2021.50251 Open-access full textSource: OpenAlex

View all 67 publications